Search Results 1021-1030 of 19872 for Receptor
... receptor signaling inhibitors (ARSIs), is often lethal. Approximately one-third of patients with mCRPC develop lethal resistant disease. Seeking answers on ...
... receptor status, and line of therapy. Subjects will continue protocol directed therapy until documentation of disease progression, development of ...
Use of chronic medications (statins, anti-inflammatory drugs, angiotensin II receptor blockers (ARBs) and/or angiotensin-converting enzyme (ACE) inhibitors).
... receptor 1 (HER1) (epidermal growth factor receptor [EGFR]) pathway; Prior therapy with trastuzumab; Prior allergic reaction to the study drugs involved in ...
At the same time, the therapeutic response to those agents varies. For example, aromatase inhibitors used to treat hormonal receptor-positive breast cancer — ...
receptors (eg, 4-1BB, OX40) - Cohort B only: - Known history of Grade 3 or higher immune-related adverse events (irAEs) that led to treatment ...
Lacy BE, Cangemi DJ. Opioids and the Gastrointestinal Tract: The Role of Peripherally Active micro-Opioid Receptor Antagonists in Modulating Intestinal ...
Mouse models of FOP have demonstrated the ability of retinoic acid receptor gamma (RARγ) agonists such as palovarotene to prevent HO following injury. This ...
No ua\se of GnRH analogues, aromatase inhimitors, selective E2 or P4 receptor modulators, oral contraceptives, or immunotherapy within 3 months prior to ...
inhibitors and GLD-1 receptor agonists. So, both of those groups of drugs, so there is lots of lots of data, very strong scientific evidence proving that ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.